Closed consultation: Proposed Regulatory Amendments for Precursor Chemicals and Designated Devices
From: Health Canada
Current status: Closed
This consultation ran from June 28, 2025 to August 12, 2025.
Canada strictly controls synthetic drugs like fentanyl and the precursor chemicals and certain drug manufacturing equipment like pill presses and encapsulators that can be used to make them. However, the illegal drug market keeps changing to try to evade these controls. Health Canada has published proposed amendments to the Precursor Control Regulations (PCR) and Schedule IX to the Controlled Drugs and Substances Act (CDSA) for public consultation. The proposed amendments would strengthen existing regulatory controls for precursors and drug equipment and provide law and border enforcement partners with new tools to support their efforts to stop illegal drug production and trafficking.
This follows a Notice of Intent that ran from January 31 to March 3, 2025. This work is one element of Canada's Border Plan in support of detecting and disrupting the illegal fentanyl trade.
Who was the focus of this consultation
We engaged with:
- licensed and registered dealers of precursors
- law enforcement
- pharmacy regulatory authorities and associations
- interested members of the public
Related information
Contact us
Office of Legislative and Regulatory Affairs
Controlled Substances and Overdose Response Directorate
Health Canada
Email: csd.regulatory.policy-politique.reglementaire.dsc@hc-sc.gc.ca